Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SLB vs GSK✓SelectedUSD · GSKSLB vs GSK performance historyLatest closeAs of-2.26%11/17
Stock and ETF performance explorer

SLB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-19.1%
GSK return
+104.0%
Excess return
-123.0%
Maximum drawdown
-84.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.3%-2.3%+0.1%-1.4%
7D-1.9%-3.0%+1.1%-0.8%
30D-1.1%+0.4%-1.5%-1.4%
3M-8.6%-1.2%-7.5%-8.7%
6M-10.7%+0.9%-11.6%-11.8%
YTD+29.6%+4.0%+25.6%+25.9%
1Y+40.1%+7.3%+32.8%+34.4%
3Y0.0%+57.1%-57.0%-20.6%
5Y+70.5%+43.0%+27.6%+38.1%
10Y-19.1%+103.1%-122.1%-42.6%
All-19.1%+104.0%-123.0%-42.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling